Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SynAm Vaccine

SynAm Vaccine?uq=UG6efJS6
2000 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
3 INVESTORS
Description

Developer of a vaccine created to eradicate pneumococcal diseases. The company's vaccine is a universal vaccine that covers all 91 bacteria serotypes such as pneumonia, middle ear infections and meningitis, enabling patients to avoid vaccine-preventable bacterial diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Biotechnology
Primary Office
  • Rockville Innovation Center
  • 155 Gibbs Street, Suite 552
  • Rockville, MD 20850
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SynAm Vaccine’s full profile, request a free trial.

SynAm Vaccine Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Grant 16-Apr-2013 0000 Completed Startup
1. Accelerator/Incubator 01-Jan-2012 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

SynAm Vaccine Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Noble Life Sciences VC-Backed Company 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
Biohealth Innovation Corporation Minority 000 0000 000000 0

SynAm Vaccine Executive Team (3)

Name Title Board
Seat
Contact
Info
Ming-chi Wu Ph.D Co-Founder, Chief Scientific Advisor & Director
Don Chen Ph.D Co-Founder, President, Chief Executive Officer & Chairman
Carolyn Chen Co-Founder & Vice President, Business Development

SynAm Vaccine Board Members (1)

Name Representing Role Since Contact
Info
Don Chen Ph.D SynAm Vaccine Co-Founder, President, Chief Executive Officer & Chairman 000 0000